Trade XCUR stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Exicure, Inc. (XCUR) is trading at US$1.31, down 4.38% today as of Sep 15, 16:00 EDT. The company has a market capitalisation of US$7.53M. Over the past 52 weeks, XCUR has traded between US$1.05 and US$9.48. On Syfe you can trade XCUR with $0 commission and add it to your watchlist.
| Previous close | US$1.37 |
|---|---|
| Market cap | US$7.53M |
| 52-week range | US$1.05 – US$9.48 |
| Volume | 17.54K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Exicure, Inc.
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Redwood City, CA.
Year: 2018
Exicure, Inc. (XCUR) stock is trading at US$1.31, -4.38% from the previous close of US$1.37.
The market cap for Exicure, Inc. (XCUR) stock is approximately US$7.53M.
The 52-week high for Exicure, Inc. (XCUR) stock is US$9.48.
The 52-week low for Exicure, Inc. (XCUR) stock is US$1.05.
Exicure, Inc. (XCUR) does not currently pay a dividend.
Stay on top of XCUR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
